These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 14641613)

  • 21. High-dose Methotrexate-induced Acral Erythema in Two Pediatric Patients With Acute Lymphoblastic Leukemia: A 17 Pediatric Case Series of Methotrexate-induced Acral Erythema.
    Noguchi K; Nishimura R; Ikawa Y; Mase S; Fujiki T; Kuroda R; Araki R; Maeba H; Yachie A; Wada T
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1259-e1261. PubMed ID: 34486565
    [No Abstract]   [Full Text] [Related]  

  • 22. Intrathecal methotrexate overdose.
    Lee AC; Wong KW; Fong KW; So KT
    Acta Paediatr; 1997 Apr; 86(4):434-7. PubMed ID: 9174236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Skin toxicity associated with bolus infusion of low-dose cytarabine].
    Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
    Rinsho Ketsueki; 2001 Mar; 42(3):216-7. PubMed ID: 11345785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
    Sterba J; Valík D; Bajciová V; Kadlecová V; Gregorová V; Mendelová D
    Neoplasma; 2005; 52(6):456-63. PubMed ID: 16284689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of anaphylactoid reactions to intravenous N-acetylcysteine.
    Bailey B; McGuigan MA
    Ann Emerg Med; 1998 Jun; 31(6):710-5. PubMed ID: 9624310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of intravenous iron formulations: facts and folklore.
    Auerbach M; Macdougall IC
    Blood Transfus; 2014 Jul; 12(3):296-300. PubMed ID: 25074787
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of an anaphylactoid reaction to methotrexate with a stepwise graded challenge.
    MacGinnitie AJ; Walensky LD; Turvey SE; Orange JS; Bonilla FA; Silverman LB; Oettgen H
    Pediatr Allergy Immunol; 2003 Oct; 14(5):409-11. PubMed ID: 14641613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Accidental shortening time of high dose methotrexate infusion: case report and literature review].
    Charfi R; Salouage I; Trabelsi S; Zarrouk M; Gaïes E; Jebabli N; Meddeb B; Lakhal M; Klouz A
    Ann Biol Clin (Paris); 2013; 71(2):219-22. PubMed ID: 23587592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use?
    Mantadakis E; Cole PD; Kamen BA
    Pharmacotherapy; 2005 May; 25(5):748-55. PubMed ID: 15899736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review.
    Pugi A; Benemei S; Vietri M; Tondo A; Calvani AM; Mugelli A; Vannacci A; Lapi F
    J Clin Pharm Ther; 2012 Apr; 37(2):245-8. PubMed ID: 21569069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Feasibility and safety of chemotherapy for acute lymphoblastic leukemia in adolescents and young adults: Interim analysis of JALSG ALL202-U].
    Kondo E
    Rinsho Ketsueki; 2012 Aug; 53(8):747-52. PubMed ID: 22975814
    [No Abstract]   [Full Text] [Related]  

  • 32. Anaphylactoid reactions to methotrexate.
    Alkins SA; Byrd JC; Morgan SK; Ward FT; Weiss RB
    Cancer; 1996 May; 77(10):2123-6. PubMed ID: 8640680
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.